臨床婦人科産科70巻5号

2016年05月発行

今月の臨床 糖尿病が女性ヘルスケア・がんに与えるリスク

糖尿病と婦人科がん

糖尿病とがんを結ぶメカニズム

著者： 佐々木浩¹

所属機関： ¹大阪医科大学産婦人科

ページ範囲：P.398 - P.404

文献概要

●本邦での大規模コホート研究によると，女性の糖尿病患者でのがん発症リスクは1.21倍であった．

●糖尿病患者におけるがん発症メカニズムは，インスリン抵抗性・高血糖・肥満などさまざまな要因が関与している．

●近年，糖尿病患者が増加していることから，糖尿病患者におけるがん予防・がん検診の重要性が増している．

参考文献

1）Giovannucci E, et al : Diabetes and cancer : a consensus report. Diabetes Care 33 : 1674─1685, 2010

2）春日雅人，他 : 糖尿病と癌に関する委員会報告．糖尿病56 : 374─390, 2013

3）Inoue M, et al : Diabetes mellitus and the risk of cancer : results from a large-scale population-based cohort study in Japan. Arch Intern Med 166 : 1871─1877, 2006

4）Ogawa W, et al : Mechanism of insulin action and diabetes mellitus. Seikagaku 75 : 1332─1344, 2003

5）Gogg S, et al : Increased MAPK activation and impaired insulin signaling in subcutaneous microvascular endothelial cells in type 2 diabetes : the role of endothelin-1. Diabetes 58 : 2238─2245, 2009

6）Renehan AG, et al : Obesity and cancer risk : the role of the insulin-IGF axis. Trends Endocrinol Metab 17 : 328─336, 2006

7）Nakae J, et al : Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev 22 : 818─835, 2001

8）Sung MK, et al : Obesity-induced metabolic stresses in breast and colon cancer. Ann N Y Acad Sci 1229 : 61─68, 2011

9）Yager JD, et al : Estrogen carcinogenesisin breast cancer. N Engl J Med 354 : 270─282, 2006

10）Chang YC, et al : The role of oxidative stress in the pathogenesis of type 2 diabetes : from molecular mechanism to clinical implication. Am J Transl Res 2 : 316─331, 2010

11）Giacco F, et al : Oxidative stress and diabetic complications. Circ Res 107 : 1058─1070, 2010

12）Ohsawa S, et al : Mitochondrial defect drives non-autonomous tumour progression through Hippo signalling in Drosophila. Nature 490 : 547─551, 2012

13）Meng D, et al : NADPH oxidase 4 mediates insulin stimulated HIF-1alpha and VEGF expression and angiogenesis in vitro. PLoS One 7 : e48393, 2012

14）Warburg O : On the origin of cancer cells. Science 123 : 309─314, 1956

15）Denko NC : Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8 : 705─713, 2008

16）Calle EE, et al : Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348 : 1625─1638, 2003

17）Renehan AG, et al : Body-mass index and incidence of cancer : a systematic review and meta-analysis of prospective observational studies. Lancet 371 : 569─578, 2008

18）Reeves GK, et al : Cancer incidence and mortality in relation to body mass index in the Million Women Study : cohort study. BMJ 335 : 1134, 2007

19）Trayhurn P, et al : Hypoxia in adipose tissue : a basis for the dysregulation of tissue function in obesity? Br J Nutr 100 : 227─235, 2008

20）Korner A, et al : Total and high-molecular-weight adiponectin in breast cancer : in vitro and in vivo studies. J Clin Endocrinol Metab 92 : 1041─1048, 2007

21）Gao J, et al : Leptin induces functional activation of cyclooxygenase-2 through JAK2 STAT3, MAPK ERK, and PI3K AKT pathways in human endometrial cancer cells. Cancer Sci 100 : 389─395, 2009

22）Calle, et al : Overweight, obesity and cancer : epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4 : 579─591, 2004

23）Sato A, et al : Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK. Stem Cells Trans Med 1 : 811─824, 2012

24）米国食品医薬品局 : 「エキセナチド添付文書」

25）米国食品医薬品局 : 「リラグルチド添付文書」

26）Nomiyama T, et al : Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth. Diabetes 63 : 3891─3905, 2014